Neuropsychological impairment in major depression: its nature, origin and clinical significance.

PubWeight™: 0.99‹?› | Rank: Top 15%

🔗 View Article (PMID 17464689)

Published in Aust N Z J Psychiatry on February 01, 2007

Authors

Richard J Porter1, Cecilia Bourke, Peter Gallagher

Author Affiliations

1: Department of Psychological Medicine, Christchurch School of Medicine and Health Sciences, PO Box 4345, Christchurch, New Zealand. richard.porter@chmeds.ac.nz

Articles citing this

Major depressive disorder is associated with broad impairments on neuropsychological measures of executive function: a meta-analysis and review. Psychol Bull (2012) 2.65

A randomized, double-blind, placebo-controlled study of vortioxetine on cognitive function in depressed adults. Int J Neuropsychopharmacol (2014) 1.30

Psychomotor retardation in depression: a systematic review of diagnostic, pathophysiologic, and therapeutic implications. Biomed Res Int (2013) 1.01

The effects of child abuse and neglect on cognitive functioning in adulthood. J Psychiatr Res (2012) 1.01

The influence of NMDA and GABA(A) receptors and glutamic acid decarboxylase (GAD) activity on attention. Psychopharmacology (Berl) (2012) 0.96

The cognitive effects of hepatitis C in the presence and absence of a history of substance use disorder. J Int Neuropsychol Soc (2009) 0.92

Cognitive functioning in severe psychiatric disorders: a general population study. Eur Arch Psychiatry Clin Neurosci (2011) 0.82

Melancholic versus non-melancholic depression: differences on cognitive function. A longitudinal study protocol. BMC Psychiatry (2010) 0.81

A follow-up study of first episode major depressive disorder. Impairment in inhibition and semantic fluency-potential predictors for relapse? Front Psychol (2013) 0.79

Effects of serotonin in the hippocampus: how SSRIs and multimodal antidepressants might regulate pyramidal cell function. CNS Spectr (2015) 0.78

Smoking history, and not depression, is related to deficits in detection of happy and sad faces. Addict Behav (2014) 0.77

Midlife Eriksonian psychosocial development: Setting the stage for late-life cognitive and emotional health. Dev Psychol (2015) 0.76

Cognitive Control Functions in Unipolar Major Depression with and without Co-Morbid Anxiety Disorder. Front Psychiatry (2010) 0.76

Social Cognition, Executive Functions and Self-Report of Psychological Distress in Huntington's Disease. PLoS Curr (2016) 0.75

Serum ApoB levels in depressive patients: associated with cognitive deficits. Sci Rep (2017) 0.75

Which Cognitive Domains are Improved by Treatment with Vortioxetine? Int J Neuropsychopharmacol (2016) 0.75

Articles by these authors

Routine versus clinically indicated replacement of peripheral intravenous catheters: a randomised controlled equivalence trial. Lancet (2012) 4.51

A meta-analysis of cognitive deficits in euthymic patients with bipolar disorder. J Affect Disord (2006) 2.72

Metabolic disease and cardiovascular risk in people treated with antipsychotics in the community. Br J Psychiatry (2007) 2.38

Neuropsychological dysfunction, soft neurological signs and social disability in euthymic patients with bipolar disorder. Br J Psychiatry (2006) 1.72

Neurocognitive impairment in drug-free patients with major depressive disorder. Br J Psychiatry (2003) 1.63

The dex/CRH test--is it better than the DST? Psychoneuroendocrinology (2006) 1.59

Neurocognitive impairment in euthymic patients with bipolar affective disorder. Br J Psychiatry (2005) 1.54

Interprofessional education for physiotherapy, medical and dietetics students: a pilot programme. J Prim Health Care (2013) 1.44

Hypothalamic-pituitary-adrenal axis function in patients with bipolar disorder. Br J Psychiatry (2004) 1.39

A controlled study of the effects of state surveillance on indicators of problematic and non-problematic benzodiazepine use in a Medicaid population. Int J Psychiatry Med (2004) 1.24

Improvements in neurocognitive function and mood following adjunctive treatment with mifepristone (RU-486) in bipolar disorder. Neuropsychopharmacology (2004) 1.24

A retrospective data analysis of the impact of the New York triplicate prescription program on benzodiazepine use in medicaid patients with chronic psychiatric and neurologic disorders. Clin Ther (2004) 1.16

Elevation of the cortisol-dehydroepiandrosterone ratio in drug-free depressed patients. Am J Psychiatry (2002) 1.14

Corticosteroid-serotonin interactions in depression: a review of the human evidence. Psychopharmacology (Berl) (2004) 1.09

The theory-practice relationship in nursing: a debate. Nurse Educ Pract (2007) 1.07

The role of mineralocorticoid receptor dysregulation in the neurocognitive impairment of patients recovered from depression: a commentary on "Associations between cognitive performance and cortisol reaction to the DEX/CRH test in patients recovered from depression" by Behnken, A., Bellingrath, S., Symanczik, J. P., Rieck, M. J., Zavorotnyy, M., Domschke, K., Arolt, V., & Zwanzger, P. doi:10.1016/j.psyneuen.2012.07.005. Psychoneuroendocrinology (2012) 1.07

Effects of state surveillance on new post-hospitalization benzodiazepine use. Int J Qual Health Care (2003) 1.01

A randomized trial to examine the effect of mifepristone on neuropsychological performance and mood in patients with bipolar depression. Biol Psychiatry (2012) 0.97

Racial disparities in access after regulatory surveillance of benzodiazepines. Arch Intern Med (2006) 0.90

White matter microstructural abnormalities in euthymic bipolar disorder. Br J Psychiatry (2010) 0.90

The effects of acute tryptophan depletion on neuropsychological function. J Psychopharmacol (2003) 0.87

Family history, early adversity and the hypothalamic-pituitary-adrenal (HPA) axis: Mediation of the vulnerability to mood disorders. Neuropsychiatr Dis Treat (2007) 0.87

How well do medical students rate and communicate clinical empathy? Med Teach (2012) 0.86

Central glucocorticoid receptor-mediated effects of the antidepressant, citalopram, in humans: a study using EEG and cognitive testing. Psychoneuroendocrinology (2011) 0.85

Changes in brain-derived neurotrophic factor following treatment with mifepristone in bipolar disorder and schizophrenia. Aust N Z J Psychiatry (2007) 0.83

The adult psychiatrist's dilemma: psychostimulant use in attention deficit/hyperactivity disorder. J Psychopharmacol (2006) 0.81

Reduced plasma levels of NGF and BDNF in patients with acute coronary syndromes. Int J Cardiol (2005) 0.81

Synthesis of 2,4,6-trisubstituted pyridines via an olefin cross-metathesis/Heck-cyclisation-elimination sequence. Chem Commun (Camb) (2011) 0.81

Performance monitoring and executive control of attention in euthymic bipolar disorder: employing the CPT-AX paradigm. Psychiatry Res (2013) 0.81

Abnormal response to failure in unmedicated major depression. J Affect Disord (2009) 0.80

Facial expression perception: an objective outcome measure for treatment studies in mood disorders? Int J Neuropsychopharmacol (2005) 0.79

Effects of intrinsic and extrinsic motivation on attention and memory. Acta Psychol (Amst) (2012) 0.79

Periventricular white matter integrity and cortisol levels in healthy controls and in euthymic patients with bipolar disorder: an exploratory analysis. J Affect Disord (2013) 0.78

Effects of acute tryptophan depletion on mood and cognitive functioning in older recovered depressed subjects. Am J Geriatr Psychiatry (2005) 0.78

Effects of acute tryptophan depletion on cognitive function in euthymic bipolar patients. Eur Neuropsychopharmacol (2002) 0.78

Effects of rapid tryptophan depletion on salivary cortisol in older people recovered from depression, and the healthy elderly. J Psychopharmacol (2006) 0.78

Lithium, arginine vasopressin and the dex/CRH test in mood disordered patients. Psychoneuroendocrinology (2007) 0.77

Cortisol awakening response and spatial working memory in man: a U-shaped relationship. Hum Psychopharmacol (2014) 0.77

Cortisol/DHEA ratios in depression. Neuropsychopharmacology (2002) 0.77

The effects of sub-chronic administration of hydrocortisone on hormonal and psychological responses to L-tryptophan in normal male volunteers. Psychopharmacology (Berl) (2002) 0.77

Elevated prolactin responses to L-tryptophan infusion in medication-free depressed patients. Psychopharmacology (Berl) (2003) 0.76

Effect of aspirin on hypothalamic-pituitary-adrenal function and on neuropsychological performance in healthy adults: a pilot study. Psychopharmacology (Berl) (2009) 0.76

Distinct cognitive phenotypes in Alzheimer's disease in older people. Int Psychogeriatr (2013) 0.76

Brain-derived neurotrophic factor in patients with remitted depression. Am J Psychiatry (2005) 0.76

Phenytoin, an anti-bipolar anticonvulsant: a potential anti-glucocorticoid mechanism? Int J Neuropsychopharmacol (2006) 0.75

Study protocol for the randomised controlled trial: antiglucocorticoid augmentation of anti-Depressants in Depression (The ADD Study). BMC Psychiatry (2013) 0.75

Post-dexamethasone arginine vasopressin levels in patients with severe mood disorders. J Psychiatr Res (2005) 0.75

Learning about public health via novels: low interest by medical students, especially relative to movies. N Z Med J (2012) 0.75

Applications of virtual reality technology in the measurement of spatial memory in patients with mood disorders. CNS Spectr (2006) 0.75

A degree of experience. Nurs Stand (2010) 0.75

Is obstetrics and gynaecology going the distance? Clin Teach (2012) 0.75

Neurocognitive dysfunction in mood disorders. Indian J Psychiatry (2003) 0.75

Movies with public health themes at a medical school library: interest and uptake. N Z Med J (2011) 0.75

Effect of sub-chronic hydrocortisone on responses to amphetamine in normal male volunteers. Psychopharmacology (Berl) (2003) 0.75

The clinical credibility of nurse educators: time the debate was put to rest. Nurse Educ Today (2010) 0.75

The impact of a change to assessment policy on students from a New Zealand school of nursing. Nurse Educ Today (2009) 0.75